Anondita Medicare SME IPO: Issue oversubscribed 60.7 times on Day 3 so far; GMP at 48%. Check key details

Anondita Medicare’s SME IPO saw robust demand on Tuesday, the final bidding day, with a grey market premium hinting at gains of over 48% on the issue price of Rs 145.

By Day 3, the issue was oversubscribed 60.72 times on the NSE, reflecting strong interest from both retail and NII investors. The stock is scheduled to list on the NSE SME platform on September 1.

Anondita Medicare IPO GMP Today:

The issue is showing strong interest in the grey market, with the latest grey market premium (GMP) at Rs 70 over the issue price of Rs 145. This suggests a potential listing gain of approximately 48%, with the listing price expected to be around Rs 215.

Anondita Medicare IPO Details:

The Rs 69.5 crore book-build issue consists entirely of a fresh issuance of 47.93 lakh equity shares. The price band is set between Rs 137 and Rs 145 per share, with a minimum application requirement of 2,000 shares, amounting to an investment of Rs 2.90 lakh at the upper price limit.

Narnolia Financial Services is the book-running lead manager, while Maashitla Securities is the registrar to the issue.

Ahead of the IPO opening, Anondita Medicare raised Rs 19.58 crore from anchor investors on August 21, 2025, by allotting 13.5 lakh shares.

Object of Issue:

The primary objectives of the issue are to support the company’s capital expenditure by financing the purchase of equipment and machinery, and to meet its working capital requirements. Additionally, a portion of the proceeds will be allocated towards funding potential unidentified acquisitions and for general corporate purposes.

About the company

Founded in March 2024, the Noida-based company manufactures male condoms under the flagship “COBRA” brand, with an annual capacity of 562 million units.

The firm exports to Southeast Asia, Africa, and the Middle East, and has partnerships with NGOs, governments, and global health organisations for family planning and public health initiatives.

The company has demonstrated impressive growth, with its revenue jumping by 66%—from Rs 46.56 crore in FY24 to Rs 77.13 crore in FY25. This significant increase reflects strong operational performance and rising demand. Additionally, profit after tax witnessed a remarkable surge of 327%, reaching Rs 16.42 crore in FY25, indicating improved efficiency and profitability.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)